17 Dec Home Office Refuses FOI Request Concerning GW Pharma’s Cannabis Licence

The Home Office and GW Pharmaceuticals – Partners In Crime

This may come as no surprise to those who already recognise the corrupt and unlawful relationship between the Home Office and GW Pharmaceuticals.

You can track this FOI request and review all correspondence here.

These are the Home Office’s reasons:

I have concluded that disclosing the information could damage the commercial interests of the GW Pharmaceuticals and also make them potential targets of criminal activity.

Releasing the information you have requested would not be in the public interest and I have, therefore, decided to withhold the requested information. The potential harm which would likely be caused to the company if the information were to be disclosed outweighs the public interest in disclosure.

This is my email requesting an internal review.

Dear Home Office,

I am writing to request an internal review of Home Office’s handling of my FOI request ‘Details of GW Pharmaceuticals licence for production of cannabis’.

This request is refused on two grounds

1. It may damage GW Pharma’s commercial interests.

This is an absurd excuse. GW has already been granted what is almost certainly an unlawful monopoly. The relationship between the Home Office and GW is self-evidently corrupt and improper. How does this square with the anti-monopoly provisions of the Enterprise Act 2002? What opportunities exist for other businesses to grow cannabis for medicine? This licence is issued by a public authority and its terms and conditions (redacted in part if necessary) should be freely available to public scrutiny.

2. It may make GW potential targets of criminal activity.

Again, an absurd excuse. The location of GW’s facilities are already public knowledge – at it’s headquarters in Porton Down, Wiltshire and at the Kent Science Park, Sittingbourne.

This is nothing but an excuse to prevent public scrutiny and amounts to an unlawful breach of the FOI Act 2000.

Yours faithfully,

Peter Reynolds

I will not acquiesce to this disgraceful and improper conduct by the Home Office. There are many routes open to challenge this and you can be certain that I will pursue them to the very end.

It is interesting that the US government, which maintains the same dishonest and corrupt position that cannabis has “no medicinal value” is about to issue an exclusive licence to Kannalife for the “development and sale of cannabinoid(s) and cannabidiol(s) based therapeutics as antioxidants and neuroprotectants for use and delivery in humans. ”